Masataka Taguri. Comments on 'A cautionary note concerning the use of stabilized weights in marginal structural models' by D. Talbot, J. Atherton, A. M. Rossi, S. L. Bacon, and G. Lefebvre. STATISTICS IN MEDICINE. 2015. 34. 8. 1438-1439
Yasutaka Chiba, Masataka Taguri. Conditional and unconditional infectiousness effects in vaccine trials. Epidemiology. 2013. 24. 2. 336-337
Taguri M, Matsuyama Y. Comments on ‘An information criterion for marginal structural models’ by R. W. Platt, A. M. Brookhart, S. R. Cole, D. Westreich, and E. F. Schisterman. Statistics in Medicine. 2013. 32. 20. 3590-3591 (letter)
Books (2):
Frontiers of Biostatistical Methods and Applications in Clinical Oncology
Springer 2017
Vaccines: Benefits and Risks
iConcept Press 2013
Lectures and oral presentations (23):
医学分野の観察研究における最近の話題と統計的課題
(統計関連学会連合大会 2016)
Bayesian optimal interval design for dose finding based on both efficacy and toxicity outcomes
(28th International Biometric Conference 2016)
構造平均モデルに基づく因果パラメータの推定とモデル選択
(日本統計学会春季集会 2016)
Causal mediation analysis with multiple causally non-ordered mediators
(International Workshop on Causal Inference 2016)
Decomposition of the population attributable fraction for two exposures
(5th East Asia Regional Biometric Conference 2015)
THE JAPANESE SOCIETY OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
, THE JAPAN STATISTICAL SOCIETY
, International Biometric Society
, JAPAN EPIDEMIOLOGICAL ASSOCIATION
, THE BIOMETRIC SOCIETY OF JAPAN